Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Urszula Janas-Skulina
Observed names:
Janas-Skulina, Urszula,
U Janas-Skulina,
U Jonas-Skulina,
U. Janas-Skulina
Institution:
Jagiellonian University
Observed institution:
Jagiellonian University
OpenAlex ID:
A5035198626
Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
1993
·
J Caban
, J Mossor-Ostrowska
, et al.
·
PubMed
·
16
Effectiveness of combined treatment with pegylated interferona-2a and ribavirin in chronic hepatitis C – study phase summary
2004
·
Katarzyna Szamotulska
, Katarzyna Sikorska
, et al.
·
Medical Science Monitor
·
14
Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b
2011
·
Tomasz H. Mach
, Andrzej Cieśla
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
12
PDF
[The influence of ursodeoxycholic acid on some biochemical, immunologic and histopathologic parameters in patients with primary biliary cirrhosis].
1999
·
D Skulina
, D Owczarek
, et al.
·
PubMed
·
8
[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)].
2005
·
Jacek Juszczyk
, Barbara Baka-Cwierz
, et al.
·
PubMed
·
7
Ribavirin and interferon alfa therapy in patients with chronic hepatitis C - preliminary observation
2000
·
W. Warunek
, M. Zejc-Bajsarowicz
, et al.
·
Journal of Hepatology
·
4
Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral hepatitis B.
1996
·
J A Georgiades
, J Caban
, et al.
·
PubMed
·
3
[Epidemiologic and clinical characteristics of patients with hepatitis type C on the bases of selected parameters].
1996
·
W Warunek
, M Librant-Suska
, et al.
·
PubMed
·
2
Safety and tolerability of the combination therapy with pegylatedinterferon alfa-2a (Pegasys®) and ribavirin (Copegus®) in patientswith chronic hepatitis C in Poland – interim analysis of data fromEAP program
2004
·
Marta Wawrzynowicz‐Syczewska
, Marek Wasilewski
, et al.
·
Medical Science Monitor
·
1
[Peginterferon alpha-2b in patients with chronic hepatitis C].
2004
·
Jacek Juszczyk
, Jolanta Białkowska
, et al.
·
PubMed
·
1
Original paper Haematological side effects in patients with chronic viral hepatitis C during treatment with alpha interferon and ribavirin
2007
·
Andrzej Cieśla
, Tomasz Mach
, et al.
·
Jagiellonian University Repository (Jagiellonian University)
PDF
[Changes of lipid metabolism in patients with chronic viral hepatitis treated with interferon alpha].
2005
·
Małgorzata Zejc-Bajsarowicz
, Andrzej Cieśla
, et al.
·
PubMed
[Clinical manifestations and effect of early therapy with interferon-alpha on the course of acute hepatitis C].
2005
·
Wioleta Warunek
, Andrzej Cieśla
, et al.
·
PubMed
Histologic changes of the liver of patients with chronic hepatitis B after interferon-α therapy
2001
·
T. Mach
, U. Janas-Skulina
, et al.
·
Journal of Hepatology
Met-enkephalin in liver as an index of hepatocellular damage
2001
·
A. Ciesla
, K. Pierzchala-Koziec
, et al.
·
Journal of Hepatology
Preliminary results of treatment of chronic hepatitis C with recombinant interferon alfa
1998
·
W. Warunek
, T. Żyrkowska-Bieda
, et al.
·
Journal of Hepatology
A comparison of histological, biochemical and serological parameters in patients with chronic hepatitis B treated with interferon-alfa
1998
·
U. Janas-Skulina
, J. Caban
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
19
Citation count:
68
H-index:
5
I10-index:
3
Year
Topic
Type
